Sibley A, Han KH, Abourached A, Lesmana LA, Makara M, Jafri W, Salupere R, Assiri AM, Goldis A, Abaalkhail F, Abbas Z, Abdou A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alavian SM, Alashgar HI, Alawadhi […]
Liakina V, Hamid S, Tanaka J, Olafsson S, Sharara AI, Alavian SM, Gheorghe L, El Hassan ES, Abaalkhail F, Abbas Z, Abdou A, Abourached A, Al Braiki F, Al Hosani F, Al Jaberi K, Al Khatry M, Al Mulla MA, Al Quraishi H, Al Rifai A, Al Serkal Y, Alam A, Alashgar HI, Alawadhi S, […]
Aghemo A, Dore GJ, Hatzakis A, Wedemeyer H, Razavi H. Estimating HCV disease burden – volume 3 (editorial). J Viral Hepat. 2015 Dec;22 Suppl 4:1-3. doi: 10.1111/jvh.12473. PMID: 26513444. Countries: Estonia, Hungary, Iceland, Indonesia, Iran, Japan, Latvia, Lebanon, Lithuania, Pakistan, Romania, Saudi Arabia, Slovenia, South Korea, United Arab Emirates
Bruggmann P, Negro F, Bihl F, Blach S, Lavanchy D, Müllhaupt B, Razavi H, Semela D. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland. Swiss Med Wkly. 2015 Dec 4;145:w14221. doi: 10.4414/smw.2015.14221. PMID: 26715488. Summary Objective In Switzerland, fewer than 40% of hepatitis C virus (HCV) infected individuals have been […]
Willemse SB, Razavi-Shearer D, Zuure FR, Veldhuijzen IK, Croes EA, van der Meer AJ, van Santen DK, de Vree JM, de Knegt RJ, Zaaijer HL, Reesink HW, Prins M, Razavi H. The estimated future disease burden of hepatitis C virus in the Netherlands with different treatment paradigms. Neth J Med. 2015 Nov;73(9):417-31. PMID: 26582807. Summary […]
Kelly E, Blach S, Razavi H, Cooper C. Interferon-based hepatitis C antiviral treatment outcomes may be predicted by alanine aminotransferase levels. Can J Gastroenterol Hepatol. 2015 Nov-Dec;29(8):407-8. doi: 10.1155/2015/897035. Epub 2015 Aug 24. PMID: 26301333; PMCID: PMC4699597. Countries: Canada
Estes C, Abdel-Kareem M, Abdel-Razek W, Abdel-Sameea E, Abuzeid M, Gomaa A, Osman W, Razavi H, Zaghla H, Waked I. Economic burden of hepatitis C in Egypt: the future impact of highly effective therapies. Aliment Pharmacol Ther. 2015 Sep;42(6):696-706. doi: 10.1111/apt.13316. Epub 2015 Jul 22. PMID: 26202593; PMCID: PMC5034818. Summary Background The prevalence of hepatitis […]
Müllhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Semela D, Negro F. Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland. PLoS One. 2015 Jun 24;10(6):e0125214. doi: 10.1371/journal.pone.0125214. PMID: 26107467; PMCID: PMC4480969. Summary Background Chronic hepatitis C virus infection is a major cause of liver disease in Switzerland […]
Stärkel P, Vandijck D, Laleman W, Van Damme P, Moreno C, Blach S, Razavi H, Van Vlierberghe H. The Disease Burden of Hepatitis C in Belgium : An update of a realistic disease control strategy. Acta Gastroenterol Belg. 2015 Jun;78(2):228-32. PMID: 26151693. Summary Background This manuscript serves as an update to position papers published in 2014 […]
Ferreira PR, Brandão-Mello CE, Estes C, Gonçales Júnior FL, Coelho HS, Razavi H, Cheinquer H, Wolff FH, Ferraz ML, Pessoa MG, Mendes-Correa MC. Disease burden of chronic hepatitis C in Brazil. Braz J Infect Dis. 2015 Jul-Aug;19(4):363-8. doi: 10.1016/j.bjid.2015.04.004. Epub 2015 Jun 4. PMID: 26051505. Summary Background Hepatitis C virus infection is a major cause […]